Revolution Medicines Inc

NASDAQ:RVMD   12:59:59 PM EDT
27.03
-1.84 (-6.37%)
Earnings Announcements

Revolution Medicines Reports Q3 Financial Results

Published: 11/10/2021 22:23 GMT
Revolution Medicines Inc (RVMD) - Revolution Medicines Reports Third Quarter Financial Results and Update on Corporate Progress.
Revolution Medicines Inc Qtrly Loss per Share 72 Cents.
Revenue is expected to be $8.99 Million
Adjusted EPS is expected to be -$0.64

Next Quarter Revenue Guidance is expected to be $11.46 Million
Next Quarter EPS Guidance is expected to be -$0.62

More details on our Analysts Page.